|
|
||||||||
1Medizinische Mikrobiologie und Immunologie, Infektabwehr. Ruhr-Universität Bochum, Bochum, Germany
2Laboratoire de Toxinologie Bacterienne et de I'institue de la Faculte de Medecine, Strasbourg, France
*Corresponding author: Professor W. König.
Received June 7, 1996
Accepted October 21, 1996
Staphylococcus aureus produces numerous bi-component toxins, e.g., Panton-Valentine leukocidin (Luk-PVL) and
-haemolysin, which consist of type S and F proteins. Previous studies showed that Luk-PVL induces inflammatory mediator release from human granulocytes that might reflect the in-vivo effects, e.g., dermonecrosis by Luk-PVL. Clinical isolates not only harbour the two genes coding for Luk-PVL (S-protein: LukS-PVL, F-protein: LukF-PVL) but also the three genes encoding
-haemolysin (S-protein: HlgA, HlgB; F-protein: HlgC). The interaction of all the possible potential toxins with human granulocytes was studied with regard to the generation of oxygen metabolites (chemiluminescence response), enzyme activity (β-glucuronidase) and histamine release as well as interleukin (IL)-8 generation. The data clearly show that the individual subunits (S, F) differ in their activities. The following activities were obtained for the S components: LukS-PVL > HlgC > HlgA: the F components LukF-PVL and HlgB were similarly active. Thus, the toxins LukS-PVL/LukF-PVL and LukS-PVL/HlgB were the most potent inducers of inflammatory mediator release from human granulocytes, followed by HlgC/LukF-PVL and HlgC/HlgB and to a lesser degree by the toxins HlgA/LukF-PVL and HlgA/HlgB. The data indicate that class S components and class F components are interchangeable and give toxins with genuine biological activities.
This article has been cited by other articles:
![]() |
M. E. Shirtliff and J. T. Mader Acute Septic Arthritis Clin. Microbiol. Rev., October 1, 2002; 15(4): 527 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Nair, R. J. Williams, and B. Henderson Advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection Rheumatology, August 1, 2000; 39(8): 821 - 834. [Full Text] [PDF] |
||||
![]() |
M. M. Dinges, P. M. Orwin, and P. M. Schlievert Exotoxins of Staphylococcus aureus Clin. Microbiol. Rev., January 1, 2000; 13(1): 16 - 34. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |